Skip to main content
SpringerLink
Log in

Radio-guided surgery with the use of [99mTc-EDDA/HYNIC]octreotate in intra-operative detection of neuroendocrine tumours of the gastrointestinal tract

  • Original Article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Purpose

Radio-guided surgery (RGS) is an intra-operative localising technique which enables identification of tissue “marked” by a specific radiotracer injected before surgery. It is mainly used for sentinel node mapping and for detection of parathyroid adenomas and other tumours, including neuroendocrine tumours of the gastrointestinal tract (GEP-NET). The aim of this study was to determine whether intra-operative radio-detection with the use of [99mTc-EDDA/HYNIC]octreotate, a new somatostatin analogue, is able to reveal an unknown primary and secondary sites, thereby improving surgical treatment and the final outcome of GEP-NET.

Methods

The study group included nine patients with suspected GEP-NET (four carcinoids, five pancreatic NET) localised with somatostatin receptor scintigraphy (with [99mTc-EDDA/HYNIC]octreotate), who had negative results on other pre-operative imaging tests. At surgery, suspected tumours were measured in situ and ex vivo and precise exploration of the abdominal cavity was performed with the intra-operative scintillation detector (Navigator).

Results

Intra-operative gamma counting localised three carcinoids. In one patient SRS was false positive (owing to inflammatory infiltration). Compared with SRS, RGS revealed additional lymph node metastases in one case. RGS resulted in successful localisation of all pancreatic NET (the smallest lesion was 8 mm in diameter).

Conclusion

[99mTc-EDDA/HYNIC]octreotate SRS followed by RGS is a promising technique to improve the rate of detection and efficacy of treatment of GEP-NET, especially in the presence of occult endocrine tumours. The imaging properties of [99mTc-EDDA/HYNIC]octreotate and the 1-day imaging protocol offer opportunities for more widespread application of this tracer followed by RGS in oncology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Benjegärd SA, Forssell-Aronsson E, Wängberg B, Skänberg J, Nilsson O, Ahlman H. Intraoperative tumour detection using 111In DTPA-D-Phe-octreotide and a scintillation detector. Eur J Nucl Med 2001;28:1456–62.

    Article  PubMed  CAS  Google Scholar 

  2. Kitagawa Y, Kitajima M. Diagnostic validity of radio-guided sentinel node mapping for gastric cancer: a review of current status and future direction. Surg Technol Int 2006;15:32–6.

    PubMed  Google Scholar 

  3. Caudle AS, Brier SE, Calvo BF, Kim HJ, Meyers MO, Ollila DW. Experienced radio-guided surgery teams can successfully perform minimally invasive radio-guided parathyroidectomy without intraoperative parathyroid hormone assays. Am Surg 2006;72:785–90.

    PubMed  Google Scholar 

  4. Bozkurt MF, Ugur O, Hamaloglu E, Sayek I, Gulec SA. Optimization of the gamma probe-guided parathyroidectomy. Am Surg 2003;69:720–5.

    PubMed  Google Scholar 

  5. Waddington WA, Kettle AG, Heddle RM, Coakley AJ. Intraoperative localization of recurrent medullary carcinoma of the thyroid using indium-111 pentetreotide and a nuclear surgical probe. Eur J Nucl Med 1994;21:363–4.

    Article  PubMed  CAS  Google Scholar 

  6. Waddington WA, Davidson BR, Todd-Pokropek A, Boulos PB, Short MD. Evaluation of a technique for the intraoperative detection of a radiolabelled monoclonal antibody against colorectal cancer. Eur J Nucl Med 1991;18:964–72.

    Article  PubMed  CAS  Google Scholar 

  7. Ramage JK, Davies AH, Ardill J, Bax N, Caplin M, Grossman A, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut 2005;54:1–16.

    Article  Google Scholar 

  8. Warner RR. Endocrine tumours other than carcinoid: a review of current clinical advances. Gastroenterology 2005;128:1668–84.

    Article  PubMed  Google Scholar 

  9. Gabriel M, Decristoforo C, Donnemiller E, Ulmer H, Watfah Rychlinski C, Mather SJ, et al. An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors. J Nucl Med 2003;44:708–16.

    PubMed  CAS  Google Scholar 

  10. Chiti A, Briganti V, Fanti S, Monetti N, Masi R, Bombardieri E. Results and potential of somatostatin receptor imaging in gastroenteropancreatic tract tumours. Q J Nucl Med 2000;44:42–9.

    PubMed  CAS  Google Scholar 

  11. Ellison EC, Schirmer WJ, Olsen JO, Pozderac RV, Hinkle G, Hill T, et al. Localization of neuroendocrine tumors using somatostatin receptor imaging with indium-111-pentetreotide (OctreoScan). Cancer Control 1997;4:35–9.

    PubMed  Google Scholar 

  12. Orlefors H, Sundin A, Garske U, Juhlin C, Oberg K, Skogseid B, et al. Whole-body 11C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography. J Clin Endocrinol Metab 2005;90:3392–400.

    Article  PubMed  CAS  Google Scholar 

  13. Adams S, Baum RP. Intraoperative use of gamma-detecting probes to localize neuroendocrine tumors. Q J Nucl Med 2000;44:59–67.

    PubMed  CAS  Google Scholar 

  14. Banzo J, Vidal-Sicat S, Prats E, Galofre G, Razola P, Mane S, et al. In-111 DTPA octreotide scintigraphy and intraoperative gamma probe detection in the diagnosis and treatment of residual lymph node metastases of a rectal carcinoid tumor. Clin Nucl Med 2005;30:308–11.

    Article  PubMed  CAS  Google Scholar 

  15. Öhrvall U, Westlin JE, Kjellberg F, Nilsson S, Juhlin C, Rastad J, et al. A gamma detector probe with ex vivo detection of carcinoid tumors superior to intraoperative palpation. Cancer 1997;80:2495–500.

    Article  PubMed  Google Scholar 

  16. Öhrvall U, Westlin JE, Nilsson S, Juhlin C, Rastad J, Lundqvist H, et al. Intraoperative gamma detection reveals abdominal endocrine tumors more efficiently than somatostatin receptor scintigraphy. Cancer 1997;80:2490–4.

    Article  PubMed  Google Scholar 

  17. Decristoforo C, Mather J, Cholewinski W, Donnemiller E, Riccabona G, Moncayo R. 99mTc EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives. Eur J Nucl Med 2000;27:1318–25.

    Article  PubMed  CAS  Google Scholar 

  18. Gabriel M, Muehllechner P, Decristoforo C, von Guggenberg E, Kendler D, Prommegger R, et al. 99mTc-EDDA/HYNIC-Tyr(3)-octreotide for staging and follow-up of patients with neuroendocrine gastro-entero-pancreatic tumours. Q J Nucl Med Mol Imaging 2005;49:237–44.

    PubMed  CAS  Google Scholar 

  19. Reubi JC, Schar JC, Waser B, Wenger S, Heppeler A, Schmitt JS, et al. Affinity profiles for human somatostatin receptor subtypes SST1–SST5 for somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med 2000;27:273–82.

    Article  PubMed  CAS  Google Scholar 

  20. Hubalewska-Dydejczyk A, Fross-Baron K, Mikolajczak R, Maecke HR, Huszno B, Pach D, et al. 99Tc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3 years’ experience. Eur J Nucl Med Mol Imaging 2006;33:1123–33.

    Article  PubMed  CAS  Google Scholar 

  21. Warner RR, O’dorisio TM. Radiolabeled peptides in diagnosis and tumor imaging: clinical overview. Semin Nucl Med 2002;32:79–83.

    Article  PubMed  Google Scholar 

  22. Guillermet-Guibert J, Lahlou H, Pyronnet S, Bousquet C, Susini C. Endocrine tumours of the gastrointestinal tract. Somatostatin receptors as tools for diagnosis and therapy: molecular aspects. Best Pract Res Clin Gastroenterol 2005;19:535–51.

    Article  PubMed  CAS  Google Scholar 

  23. Bertherat J, Tenenbaum F, Perlemoine K, Videau C, Alberini JL, Richard B, et al. Somatostatin receptors 2 and 5 are the major somatostatin receptors in insulinomas: an in vivo and in vitro study. J Clin Endocrinol Metab 2003;88:5353–60.

    Article  PubMed  CAS  Google Scholar 

  24. Krenning EP, Kwekkeboom DJ, Bakker WA, Breeman WA, Kooij PP, Oei HY, et al. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe]octreotide and [123I-tyr]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993;20:716–31.

    Article  PubMed  CAS  Google Scholar 

  25. Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol 1999;20:157–98.

    Article  PubMed  CAS  Google Scholar 

  26. Fettich J, Repse S, Snoj M, Zitko-Krhin M, Markovic M. 99mTc-EDDA/HYNIC-TOC is a suitable radiopharmaceutical for radioguided surgery of neuroendocrine tumours. Abstract book of International Symposium on Trends in Radiopharmaceuticals (ISTR) Vienna, Austria 2005; p 25–26 (IAEA-CN-130/015)

  27. Behe M, Maecke HR. New somatostatin analogues labelled with technetium-99m [abstract]. Eur J Nucl Med 1995;22:791.

    Google Scholar 

  28. Storch D, Béhé M, Walter MA, Chen J, Powell P, Mikolajczak R, et al. Evaluation of [99mTc/EDDA/HYNIC]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: Does tumor or pancreas uptake correlate with the rate of internalisation? J Nucl Med 2005;46:1561–9.

    PubMed  CAS  Google Scholar 

  29. Adams S, Baum RP, Hertel A, Wenisch HJ, Staib-Sebler E, Herrmann G, et al. Intraoperative gamma probe detection of neuroendocrine tumors. J Nucl Med 1998;39:1155–60.

    PubMed  CAS  Google Scholar 

  30. Huai JC, Zhang W, Niu HO, Su ZX, McNamara JJ, Machi J. Localization and surgical treatment of pancreatic insulinomas guided by intraoperative ultrasound. Am J Surg 1998;175:18–21.

    Article  PubMed  CAS  Google Scholar 

  31. Hashimoto LA, Walsh RM. Preoperative localization of insulinomas is not necessary. J Am Coll Surg 1999;189:368–73.

    Article  PubMed  CAS  Google Scholar 

  32. Oberg K, Eriksson B. Endocrine tumours of the pancreas. Best Pract Res Clin Gastroenterol 2005;19:753–81.

    Article  PubMed  CAS  Google Scholar 

  33. Norton JA, Sigel B, Baker AR, Ettinghausen SE, Shawker TH, Krudy AG, et al. Localization of an occult insulinoma by intraoperative ultrasonography. Surgery 1985;97:381–4.

    PubMed  CAS  Google Scholar 

  34. Brown K, Kristopaitis T, Yong S, Chejfec G, Pickleman J. Cystic glucagonoma: a rare variant of an uncommon neuroendocrine pancreas tumor. J Gastrointest Surg 1998;2:533–6.

    Article  PubMed  CAS  Google Scholar 

  35. Harris C, Bieglow R, Francis J, Kelley G, Bell P. A CsI(Tl)-crystal surgical scintillation probe. Nucleonics 1956;14:102–8.

    Google Scholar 

  36. Kowalski J, Henze M, Schuhmacher J, Macke HR, Hofmann M, Haberkorn U. Evaluation of positron emission tomography imaging using 68Ga-DOTAD Phe1-Tyr3)-octreotide in comparison to 111In-DTPAOC SPECT. First results in patients with neuroendocrine tumors. Mol Imaging Biol 2003;5:42–8.

    Article  PubMed  Google Scholar 

  37. Raylman RR. Performance of a dual, solid-state intraoperative probe system with 18F, 99mTc, and 111In. J Nucl Med 2001;42:352–60.

    PubMed  CAS  Google Scholar 

  38. Pitre S, Menard L, Ricard M, Solal M, Garbay JR, Charon Y. A hand-held imaging probe for radio-guided surgery: physical performance and preliminary clinical experience. Eur J Nucl Med Mol Imaging 2003;30:339–43.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nuclear Medicine Unit of the Department of Endocrinology, Medical College at Jagiellonian University, 31-501, Cracow, Poland

    A. Hubalewska-Dydejczyk, D. Pach, A. Sowa-Staszczak, K. Fröss-Baron & B. Huszno

  2. The Gastrointestinal and General Surgery Department, Medical College at Jagiellonian University, Cracow, Poland

    J. Kulig & P. Szybinski

  3. Radioisotope Centre POLATOM, Otwock-Swierk, Poland

    R. Mikolajczak

  4. Kopernika Str. 17, Krakow, Poland

    A. Hubalewska-Dydejczyk

Authors
  1. A. Hubalewska-Dydejczyk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Kulig
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Szybinski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Mikolajczak
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Pach
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Sowa-Staszczak
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. K. Fröss-Baron
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. B. Huszno
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Hubalewska-Dydejczyk.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hubalewska-Dydejczyk, A., Kulig, J., Szybinski, P. et al. Radio-guided surgery with the use of [99mTc-EDDA/HYNIC]octreotate in intra-operative detection of neuroendocrine tumours of the gastrointestinal tract. Eur J Nucl Med Mol Imaging 34, 1545–1555 (2007). https://doi.org/10.1007/s00259-007-0476-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-007-0476-4

Keywords

Search

Navigation